Variant report
Variant | nsv517812 |
---|---|
Chromosome Location | chr7:140009332-140010108 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:10)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:10 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:140009860..140010445-chr7:140095992..140096644,2 | MCF-7 | breast: | |
2 | chr7:139875119..139878535-chr7:140008381..140012016,6 | MCF-7 | breast: | |
3 | chr7:140009936..140012415-chr7:140015586..140017552,2 | MCF-7 | breast: | |
4 | chr7:140004952..140007749-chr7:140008011..140010773,2 | MCF-7 | breast: | |
5 | chr7:140000240..140002931-chr7:140009039..140011933,3 | MCF-7 | breast: | |
6 | chr7:140003129..140009929-chr7:140011645..140017997,10 | MCF-7 | breast: | |
7 | chr20:52811659..52812164-chr7:140009869..140010808,2 | MCF-7 | breast: | |
8 | chr7:140009929..140010746-chr7:140096072..140096776,2 | MCF-7 | breast: | |
9 | chr7:140009842..140010440-chr7:140096015..140096525,2 | MCF-7 | breast: | |
10 | chr7:139875379..139877592-chr7:140008407..140010422,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000006459 | chromatin interactions |
ENSG00000260231 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7792748 | chr7:140009332-140009333 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs565490855 | chr7:140009373-140009374 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs553253591 | chr7:140009381-140009382 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs143286555 | chr7:140009398-140009399 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs373776923 | chr7:140009440-140009441 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs537367177 | chr7:140009455-140009456 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs555569459 | chr7:140009459-140009460 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs542299668 | chr7:140009491-140009492 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs10085655 | chr7:140009500-140009501 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs148334885 | chr7:140009574-140009575 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs141512982 | chr7:140009579-140009580 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs13227511 | chr7:140009590-140009591 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs375699658 | chr7:140009604-140009605 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs542052505 | chr7:140009637-140009638 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs577950197 | chr7:140009649-140009650 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs57537546 | chr7:140009662-140009663 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs13222275 | chr7:140009673-140009674 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs563615829 | chr7:140009690-140009691 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs13227641 | chr7:140009718-140009719 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs368528704 | chr7:140009772-140009773 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs531080442 | chr7:140009786-140009787 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs549281487 | chr7:140009792-140009793 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs13222402 | chr7:140009795-140009796 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs528685248 | chr7:140009796-140009797 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs547170228 | chr7:140009798-140009799 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs565806678 | chr7:140009801-140009802 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs539420703 | chr7:140009802-140009803 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs551369571 | chr7:140009803-140009804 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs13222411 | chr7:140009808-140009809 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs569686883 | chr7:140009826-140009827 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs72584745 | chr7:140009850-140009851 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs28527343 | chr7:140009851-140009852 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs78054064 | chr7:140009852-140009853 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs537305094 | chr7:140009869-140009870 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs4725675 | chr7:140009905-140009906 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs73479826 | chr7:140009916-140009917 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs534859671 | chr7:140009935-140009936 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs543973174 | chr7:140009967-140009968 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs578068772 | chr7:140009987-140009988 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs28483540 | chr7:140010051-140010052 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs530585316 | chr7:140010065-140010066 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs138530331 | chr7:140010066-140010067 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs563307654 | chr7:140010098-140010099 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs575243333 | chr7:140010100-140010101 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs11764865 | chr7:140010108-140010109 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Melanoma | 19188590 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Coffin-Siris syndrome | 21572526 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Bladder cancer | 21909424 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
T-cell acute lymphoblastic leukemia | 16673021 | CNVD |
Cancer | 21183584 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Developmental delay | 19490664 | CNVD |
Pancreatitis | 20877625 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Low-grade astrocytoma | 19016743 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Pilocytic astrocytoma | 18408760 | CNVD |
Idiopathic chronic pancreatitis | 19584086 | CNVD |
Pediatric low-grade astrocytoma | 19016743 | CNVD |
Acute lymphoblastic leukemia | 17315016 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17440070 | CNVD |
Astrocytoma | 18398503 | CNVD |
Melanoma | 19671679 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:140003400-140010000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr7:140004600-140010200 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
3 | chr7:140004600-140011200 | Enhancers | HepG2 | liver |
4 | chr7:140004600-140015400 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
5 | chr7:140006000-140015400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr7:140006800-140009400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
7 | chr7:140007000-140011600 | Weak transcription | Primary B cells from cord blood | blood |
8 | chr7:140007400-140010800 | Enhancers | Ovary | ovary |
9 | chr7:140008400-140010000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr7:140008400-140014800 | Weak transcription | Stomach Mucosa | stomach |
11 | chr7:140008800-140009400 | Enhancers | Colonic Mucosa | Colon |
12 | chr7:140008800-140010400 | Enhancers | Colon Smooth Muscle | Colon |
13 | chr7:140008800-140012200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
14 | chr7:140009200-140010200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
15 | chr7:140009200-140010800 | Enhancers | A549 | lung |
16 | chr7:140009400-140014800 | Weak transcription | Colonic Mucosa | Colon |
17 | chr7:140009400-140015000 | Enhancers | Primary monocytes fromperipheralblood | blood |
18 | chr7:140009800-140010200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
19 | chr7:140009800-140011000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
20 | chr7:140010000-140010200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
21 | chr7:140010000-140010400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
22 | chr7:140010000-140011000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |